Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cygnus gains development grants for GlucoWatch:

This article was originally published in Clinica

Executive Summary

Cygnus has received two grants worth a total of $200,000 from the US National Institutes of Health to support the development of its noninvasive, automatic glucose monitoring system, the GlucoWatch Biographer. The first grant will be used to develop a method for predicting hypoglycaemic events, while the second will focus on using a predictive kinetic method to reduce the effects of certain variables on results obtained with the Biographer. The FDA granted Redwood City, California-based Cygnus an approvable letter for its GlucoWatch in May.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075390

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel